Keck School Faculty

Nathan John Robison, MD
Nathan John Robison, MD
Assistant Professor of Clinical Pediatrics
CHL Mail Stop 54 Off Campus Los Angeles
After completing his residency and fellowship at Children’s Hospital Los Angeles, Dr. Robison completed an additional fellowship in Pediatric Neuro-Oncology at the Dana-Farber / Children’s Hospital Cancer Center in Boston. He served as clinical instructor at Harvard Medical School and attending staff in the Pediatric Neuro-Oncology Program at Dana Farber Cancer Institute and Boston Children’s Hospital from 2010 to 2013.

In April 2013 he joined the faculty of the University of Southern California Keck School of Medicine as assistant professor of pediatrics, and now serves as attending staff in the Pediatric Neuro-Oncology Program at Children's Hospital Los Angeles.

Dr. Robison's primary research focus is developing clinical trials that test new strategies in the treatment of children with brain tumors. Specific areas of interest include molecular targeted treatment of low-grade glioma, diffuse pontine glioma, and medulloblastoma; novel treatments targeting the tumor microenvironment, including antiangiogenic and immunomodulatory strategies; and neurofibromatosis.

Clinical and neuropsychological outcome of pediatric non-midline central nervous system germinoma treated with chemotherapy and reduced dose/volume irradiation: The Children's Hospital Los Angeles experience Pediatr Blood Cancer. 2019 Dec; 66(12):e27983. . View in PubMed

Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens J Neurooncol. 2019 Nov; 145(2):375-383. . View in PubMed

Unusual radiological and histological presentation of a diffuse leptomeningeal glioneuronal tumor (DLGNT) in a 13-year-old girl Childs Nerv Syst. 2019 Sep; 35(9):1609-1614. . View in PubMed

Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy Oncotarget. 2019 Jan 11; 10(4):551-557. . View in PubMed

A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children's Oncology Group J Neurooncol. 2018 Dec; 140(3):575-582. . View in PubMed

Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors J Neurooncol. 2018 May; 138(1):199-207. . View in PubMed

Changing Trends in Brain Imaging Technique for Pediatric Patients with Ventriculoperitoneal Shunts Pediatr Neurosurg. 2018; 53(2):116-120. . View in PubMed

Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma Neuro Oncol. 2018 10 09; 20(11):1547-1555. . View in PubMed

Novel GOPC(FIG)-ROS1 fusion in a pediatric high-grade glioma survivor J Neurosurg Pediatr. 2017 Jul; 20(1):51-55. . View in PubMed

Successful Treatment of Recurrent Li-Fraumeni Syndrome-related Choroid Plexus Carcinoma J Pediatr Hematol Oncol. 2017 11; 39(8):e473-e475. . View in PubMed

Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy Neuro Oncol. 2016 Jan; 18(1):126-31. . View in PubMed

Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group report Cancer. 2015 Dec 01; 121(23):4205-11. . View in PubMed

Tumor-associated macrophages in SHH subgroup of medulloblastomas Clin Cancer Res. 2015 Mar 15; 21(6):1457-65. . View in PubMed

Diffuse intrinsic pontine glioma: a reassessment J Neurooncol. 2014 Aug; 119(1):7-15. . View in PubMed

Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database Pediatr Blood Cancer. 2014 Jul; 61(7):1173-9. . View in PubMed

A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer Pediatr Blood Cancer. 2014 Apr; 61(4):636-42. . View in PubMed

PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas Clin Cancer Res. 2014 Feb 15; 20(4):827-36. . View in PubMed

Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells Clin Immunol. 2013 Oct; 149(1):55-64. . View in PubMed

Predictors of neoplastic disease in children with isolated pituitary stalk thickening Pediatr Blood Cancer. 2013 Oct; 60(10):1630-5. . View in PubMed

Morning glory disc anomaly in association with ipsilateral optic nerve glioma Arch Ophthalmol. 2012 Aug; 130(8):1082-3. . View in PubMed

Identification of novel biologic targets in the treatment of newly diagnosed diffuse intrinsic pontine glioma Am Soc Clin Oncol Educ Book. 2012; 625-8. . View in PubMed

Diffuse central neurocytoma with craniospinal dissemination J Clin Neurosci. 2012 Jan; 19(1):163-6. . View in PubMed

Cerebral sinus thrombosis in a child with active ulcerative colitis and factor V Leiden Pediatr Blood Cancer. 2009 Jul; 52(7):867-9. . View in PubMed

Causes of nursery death beyond the neonatal period J Perinatol. 2003 Mar; 23(2):142-7. . View in PubMed

Powered by SC CTSI
Go to Top